Dr. Sameem M. Abedin
Claim this profileMedical College of Wisconsin
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
14 reported clinical trials
33 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
FLT3 positive
D835 positive
RUNX1-RUNX1T1 negative
2Acute Myeloid Leukemia
FLT3 positive
D835 positive
RUNX1-RUNX1T1 negative
Affiliated Hospitals
Clinical Trials Sameem M. Abedin is currently running
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting1 award Phase 27 criteria
Venetoclax, Azacitidine, and Cusatuzumab
for Acute Myeloid Leukemia
The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to venetoclax and azacitidine. Venetoclax and azacitidine are drugs commonly used to treat AML in patients that are unable to receive chemotherapy to treat AML. The main question the clinical trial aims to answer is does cusatuzumab added to venetoclax and azacitidine prolong the length of time participants live compared to venetoclax and azacitidine?
Recruiting1 award Phase 21 criteria
More about Sameem M. Abedin
Clinical Trial Related6 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sameem M. Abedin has experience with
- Cyclophosphamide
- Ruxolitinib
- Venetoclax
- Gilteritinib
- Neihulizumab
- Cytarabine
Breakdown of trials Sameem M. Abedin has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Acute Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sameem M. Abedin specialize in?
Sameem M. Abedin focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 positive patients, or patients who are D835 positive.
Is Sameem M. Abedin currently recruiting for clinical trials?
Yes, Sameem M. Abedin is currently recruiting for 5 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Sameem M. Abedin has studied deeply?
Yes, Sameem M. Abedin has studied treatments such as Cyclophosphamide, Ruxolitinib, Venetoclax.
What is the best way to schedule an appointment with Sameem M. Abedin?
Apply for one of the trials that Sameem M. Abedin is conducting.
What is the office address of Sameem M. Abedin?
The office of Sameem M. Abedin is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.